Results 191 to 200 of about 4,627,535 (339)

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.

Journal of Clinical Oncology, 2013
A. Prat, M. Cheang, Miguel Martín, J. Parker, E. Carrasco, R. Caballero, S. Tyldesley, K. Gelmon, P. Bernard, T. Nielsen, C. Perou   +10 more
semanticscholar   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Prognostic impact of progesterone receptor status in patients with breast cancer and isolated locoregional recurrence. [PDF]

Breast Cancer
Murata T, Kumamaru H, Yoshida M, Kinukawa N, Takayama S, Suto A, Jinno H, Ishida T, Niikura N, Saji S.   +9 more
europepmc   +1 more source

Efficacy of vaginal progesterone capsules in preventing preterm birth in women with subchorionic hematoma complicated by preterm labor or preterm prelabor rupture of membranes: A case–control observational study

International Journal of Gynecology &Obstetrics, EarlyView.
Eriko Yasuda, Yusuke Ueda, Taito Miyamoto, Yosuke Kawamura, Yoshitsugu Chigusa, Masaki Mandai, Haruta Mogami   +6 more
wiley   +1 more source

S100A8/A9 Drives Emergency Granulopoiesis to Promote Triple‐Negative Breast Cancer Metastasis

iNew Medicine, EarlyView.
ABSTRACT Objective Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by high metastatic potential and limited therapeutic options. Although neutrophils contribute to tumor progression, how tumors systemically regulate neutrophil production remains poorly understood.
Hami Hemati, Dong Li, Younhee Park, Jinpeng Liu, Xueqing Wang, Xia Liu   +5 more
wiley   +1 more source

Serum Response Factor Cooperates With Progesterone Receptor to Regulate Oviductal Smooth Muscle Gene Expression During Preimplantation Embryo Transport. [PDF]

FASEB J
Lais PF, Marquardt RM, Wu SP, Lydon JP, DeMayo FJ.   +4 more
europepmc   +1 more source

Toxic Effects of Bisphenol A and Its Analogs on Ovarian Structure and Function: A Narrative Review of Ovary‐Focused Studies

Journal of Applied Toxicology, EarlyView.
ABSTRACT Bisphenol A (BPA) is a widely used industrial chemical found in polycarbonate plastics and epoxy resins and is recognized for its endocrine‐disrupting properties. Human exposure is common due to its presence in food packaging and everyday products. As BPA use has been restricted, structurally similar compounds such as BPS, BPB, BPAF, and BADGE
Nurbanu Zengin, Marwa Tawfıq Ahmed Alsalım, Muhammed Canik, Sevda Bağdatlı, Nazan Deniz Yön   +4 more
wiley   +1 more source

Progesterone Receptor Expression in the Human Enteric Nervous System. [PDF]

Int J Mol Sci
Kallabis N, Neufeld PM, Yurchenko A, Matschke V, Nettersheim R, Vorgerd M, Theiss C, Stahlke S.   +7 more
europepmc   +1 more source

Comparison of Continuous‐Time Random Walk and Fractional Order Calculus Diffusion Models for Preoperative Breast Lesion Characterization: Diagnosis, Biomarker Prediction and Molecular Subtyping

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Accurate preoperative characterization of breast lesions is important for individualized management. The conventional monoexponential (Mono) model has limited ability to capture the complex microstructure of lesions. Non‐Gaussian diffusion models, including continuous‐time random walk (CTRW) and fractional‐order calculus (FROC), may
Yimeng Cao, Shaomin Li, Zhexuan Yang, Xueyan Liu, Shifang Tan, Tian Ren, Wenjia Wang, Haiyang Li, Xingzhi Chen, Xin Zhao, Meiying Cheng   +10 more
wiley   +1 more source

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers. [PDF]

NPJ Breast Cancer
Widschwendter M, Schmutzler R, Pashayan N, Wesseling J, Tischkowitz M, Zikan M, Steenbeek M, Gabrielson M, Singer CF, Brisken C, Gomperts R, Cameron S, Evans DG, Papakonstantinou A, Buyse M, Rhiem K, Krajc M, Vavourakis C, Redl E, Herzog C, Barrett J, Rasul MF, Utjés D, Papaikonomou K, Rådestad AF, Zouzos A, Alkasalias T, Gemzell-Danielsson K.   +27 more
europepmc   +1 more source